Gilead defeats immunity bid in hepatitis C patent case

07-03-2023

Muireann Bolger

Gilead defeats immunity bid in hepatitis C patent case

shutterstock_1569359980_Sundry Photography

The University of Minnesota had raised three key issue on appeal | Sovereign immunity was at the heart of the years-long dispute.


Gilead, hepatitis C, patents, sovereign immunity, University of Minnesota, US Court of Appeals for the Federal Circuit, PTAB, Supreme Court

LSIPR